Charles Albright, EVP/Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 40,000 shares at $40.02 ($1.6M) on 2020-12-07, disclosed to the SEC on 2020-12-08.
Open-market sale of $1.6M EDIT by EVP/Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 20,000 | $800K | 50.0% |
| 2 | $40.02 | 20,000 | $800K | 50.0% |
| Total | $40.02 avg | 40,000 | $1.6M | 100% |
| Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |
| EDIT | SELL | 2020-08-19 | $353K | — | Filing → |